Biomatters

Biomatters is an applied bioinformatics company that creates integrated bioinformatics software. Biomatters was founded in 2003 and headquartered in New Zealand with an office in the United States, and users in 125 countries worldwide, their solutions enhance productivity in more than 4,000 universities, research institutes and businesses.[1] Notable Biomatters partners include Harvard University, Pfizer, GSK and more.[2]

Software

Biomatters creates powerful and visually appealing bioinformatics solutions, with an emphasis on ease of use and overall great user experience. We are the market leaders in bioinformatics, constantly iterating and innovating to ensure our software solutions deliver everything our customers need.[1] Biomatters flagship software is Geneious Prime, a suite of molecular biology and NGS analysis tools.[3] In December 2017 Biomatters released a new enterprise software, Geneious Biologics, which is targeted at companies engaged in commercial antibody screening.[4]

Awards

Biomatters has won a number of awards including:

  • 2007: Computerworld Excellence Awards from Innovative Use of ICT[5]
  • 2009: Recruit IT Innovative Software Product Award at the PriceWaterhouseCoopers Hi-Tech Awards[6]
  • 2012: Microsoft Hi-Tech Emerging Company Award[6]
  • 2015: Best of Show Finalist at the Bio-IT World Awards in Boston[7]

References
  1. "About Biomatters".
  2. "Customers | Geneious Prime". Geneious. Retrieved 7 February 2022.
  3. "Geneious Prime".
  4. "Geneious Biologics".
  5. "ComputerWorld Excellence Awards".
  6. "Winners – HITECH Awards". www.hitech.org.nz. Retrieved 16 November 2016.
  7. "Bio-IT World Recognizes 2015 Best of Show Winners". www.bio-itworld.com.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.